Emily K. Curran - Department of Neurology, Stanford University

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 92 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed NPM1-Mutated or KMT2A-Rearranged AML

Joshua F Zeidner,Tara L Lin, Rina Li Welkie,Emily Curran, Kristin Koenig,Wendy Stock, Yazan F Madanat,Ronan Swords,Maria R Baer,William Blum, Eytan M Stein,Rebecca L Olin,Gary Schiller, Angela Nichols,Olatoyosi Odenike,Elie Traer, Curtis Lachowiez, Vu H Duong,Michael J Hochman,Sheng F Cai, Catherine Smith,Mona Stefanos, Molly Martycz,Ying Huang, Len Rosenberg, Sonja Marcus, Timothy L Chen, Ashley O Yocum,Brian J Druker,Ross L Levine,Uma Borate, John C Byrd,Alice S Mims

Journal of clinical oncology official journal of the American Society of Clinical Oncologypp.JCO2500914-JCO2500914, (2025)

Cited0Views0WOSBibtex

Recognition, Prevention, and Management of Adverse Events Associated with Asparaginase / Pegaspargase Treatment of Acute Lymphoblastic Leukemia in Adults: Consensus of an Expert Panel

Emily Curran,Marlise R Luskin,Houda Alachkar,Ibrahim Aldoss,Patrick W Burke,Ryan D Cassaday,Seth E Karol,Anthony J Perissinotti, Cecilie Utke Rank,Kjeld Schmiegelow,Jonathan Webster,Dan Douer

Haematologica (2025)

Cited0Views0WOSBibtex

Guideline-concordant Treatment among Adolescents and Young Adults with Acute Lymphoblastic Leukemia

Julie A Wolfson, Allison C Grimes,Michelle M Nuño, Subhash Ramakrishnan, David S Dickens, Michael E Roth, Wendy Woods, Kandice S Adams, Tawa Alabi,Melissa Beauchemin, Jennifer M Levine, Michele Scialla, Koh B Boayue, Charlotte L Kerber, Olivia Ponce,Sarah Vargas, George J Chang,Wendy Stock, Dawn Hershman,Emily Curran, Anjali Advani, Kristen O'Dwyer,Selina Luger, Jane Jijun Liu,David R Freyer,Lillian Sung,Susan K Parsons

JNCI cancer spectrumno. 3 (2025)

Cited0Views0WOSBibtex

Characteristics of Health Care Settings Where Adolescents and Young Adults Receive Care for ALL

Julie A. Wolfson,Allison C. Grimes,Michelle Nuno, Charlotte L. Kerber,Subhash Ramakrishnan,Melissa Beauchemin,David Dickens,Jennifer M. Levine,Michael E. Roth, Michele Scialla, Wendy Woods,Sarah Vargas, Koh B. Boayue,George J. Chang,Wendy Stock,Dawn Hershman,Emily Curran,Anjali Advani,Kristen O'Dwyer,Selina Luger,Jane Jijun Liu,David R. Freyer,Lillian Sung,Susan K. Parsons

JCO Oncology Practiceno. 4 (2024): 491-502

Cited1Views0WOSBibtex

A Phase 1, Multicenter, Open-Label, Dose-Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Clinical Activity of Orally Administered LP-108 (lacutoclax) As Monotherapy and in Combination with Azacitidine in Subjects with Relapsed or Refractory Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia..

Juan Miguel Bergua Burgues,Kristin Koenig,Pau Montesinos,Dale L. Bixby,Patrick W. Burke,Naval Daver,Stephen P. Anthony,Fenlai Tan, Yi Chen, Yu Chen,Ignacio Casas Aviles,Emily K. Curran

BLOOD (2024): 6009-6010

Cited0Views0Bibtex

The Incidence of CNS Relapse in Philadelphia Chromosome Positive (ph+) Acute Lymphoblastic Leukemia (ALL) and Its Impact on Clinical Outcome: Results from Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)

Kashish J. Shah, Mobachir El Kettani,Ravi Narra,Alice Mims,Alexander Coltoff, Georgio Medawar, Brooke Hisrich,Rory M. Shallis, Cameron J. Hunter,Vamsi K. Kota,Tamer Othman,Brian A. Jonas,Shreya Desai,Guilherme Sacchi de Camargo Correia,Anand Ashwin Patel,Adam S. Duvall,Neil D. Palmisiano,Emily K Curran,Zulfa Omer,Anjali S. Advani,Ehab L. Atallah,Mark R. Litzow,Talha Badar

Bloodno. Supplement 1 (2024): 4184-4184

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn